Perceptive Advisors’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-1,966
| Closed | -$8K | – | 182 |
|
|
2017
Q1 | $8K | Sell |
1,966
-544,532
| -100% | -$2.22M | ﹤0.01% | 149 |
|
|
2016
Q4 | $2.36M | Sell |
546,498
-22,522
| -4% | -$97.1K | 0.17% | 79 |
|
|
2016
Q3 | $5.6M | Hold |
569,020
| – | – | 0.36% | 63 |
|
|
2016
Q2 | $3.22M | Hold |
569,020
| – | – | 0.22% | 67 |
|
|
2016
Q1 | $4.34M | Hold |
569,020
| – | – | 0.38% | 57 |
|
|
2015
Q4 | $7.58M | Sell |
569,020
-22,130
| -4% | -$295K | 0.56% | 40 |
|
|
2015
Q3 | $1.38M | Buy |
591,150
+33,334
| +6% | +$77.8K | 0.11% | 79 |
|
|
2015
Q2 | $12.5M | Buy |
557,816
+403,649
| +262% | +$9.06M | 0.75% | 31 |
|
|
2015
Q1 | $1.51M | Buy |
154,167
+100,000
| +185% | +$978K | 0.12% | 82 |
|
|
2014
Q4 | $618K | Hold |
54,167
| – | – | 0.05% | 102 |
|
|
2014
Q3 | $624K | Buy |
54,167
+5,370
| +11% | +$61.9K | 0.06% | 82 |
|
|
2014
Q2 | $949K | Sell |
48,797
-41,703
| -46% | -$811K | 0.09% | 75 |
|
|
2014
Q1 | $1.62M | Buy |
90,500
+7,167
| +9% | +$129K | 0.17% | 68 |
|
|
2013
Q4 | $880K | Buy |
83,333
+2,916
| +4% | +$30.8K | 0.11% | 62 |
|
|
2013
Q3 | $994K | Buy |
+80,417
| New | +$994K | 0.08% | 59 |
|